[Form 4] Omada Health, Inc. Insider Trading Activity

Rhea-AI Filing Summary

Omada Health, Inc. director Jeryl L. Hilleman received an equity grant of 1,601 shares of Common Stock on 01/05/2026, reported as an acquisition at a price of $0 per share. The filing explains this represents restricted stock units (RSUs) granted under the company’s Non-Employee Director Compensation Program in lieu of cash retainer fees, with each RSU convertible into one share of common stock at settlement. Following this grant, Hilleman beneficially owns 12,794 shares of Omada Health common stock in direct ownership.

Insider Trade Summary

Net Buyer: 1,601 shares

Net Buy 1 txn

Insider HILLEMAN JERYL L

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	1,601	$0.00	$0.00

Holdings After Transaction: Common Stock — 12,794 shares (Direct)

Footnotes (1)

1. F1. Represents restricted stock units ("RSUs") that were granted pursuant to the Issuer's Non-Employee Director Compensation Program (the "Program") in lieu of retainer fees. Each RSU represents the right to receive one (1) share of Common Stock, with settlement to take place either (i) on a date selected by the Reporting Person pursuant to the Program or (ii) as otherwise provided by the Program.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

Accepted by SEC EDGAR 01/07/2026 - 05:36 PM Learn about SEC filing dates

FAQ

What did Omada Health (OMDA) report in this Form 4 filing?

The filing reports that director Jeryl L. Hilleman acquired 1,601 shares of Omada Health common stock on 01/05/2026, recorded at a price of $0 per share.

How many Omada Health shares does Jeryl L. Hilleman now beneficially own?

After the reported transaction, Jeryl L. Hilleman beneficially owns 12,794 shares of Omada Health common stock in direct ownership.

What is the nature of the 1,601 Omada Health shares reported in this Form 4?

The 1,601 shares represent restricted stock units (RSUs) granted under Omada Health’s Non-Employee Director Compensation Program in lieu of retainer fees.

How do the RSUs granted to the Omada Health director convert into shares?

Each RSU granted to the director represents the right to receive one share of Omada Health common stock, with settlement on a date selected by the reporting person or as otherwise provided by the program.

Was any cash paid for the 1,601 Omada Health shares in this transaction?

No cash was paid for these shares; the Form 4 shows the 1,601 shares acquired at a price of $0 per share as part of director compensation in stock units.

What role does Jeryl L. Hilleman hold at Omada Health?

Jeryl L. Hilleman is reported as a director of Omada Health, Inc. and is not listed as an officer or 10% owner in this filing.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

HILLEMAN JERYL L

(Last) (First) (Middle)

C/O OMADA HEALTH, INC.

611 GATEWAY BLVD., SUITE 120

(Street)

SOUTH SAN FRANCISCO CA 94080

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Omada Health, Inc. [ OMDA ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
01/05/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	01/05/2026		A		1,601(1)	A	$0	12,794	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents restricted stock units ("RSUs") that were granted pursuant to the Issuer's Non-Employee Director Compensation Program (the "Program") in lieu of retainer fees. Each RSU represents the right to receive one (1) share of Common Stock, with settlement to take place either (i) on a date selected by the Reporting Person pursuant to the Program or (ii) as otherwise provided by the Program.

	/s/ Nathan Salha, as Attorney-in-Fact for Jeryl L. Hilleman	01/07/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.